Track the latest Ernexa Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Ernexa Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
Apr 04, 2025 | Charles Cherington | 10% OWNER | 3.77M | $0.10 | $394.17K | BUY | 22.66% | 20.40M | Apr 02 | View |
Dec 06, 2022 | Charles Cherington | — | 261.76K | $3.28 | $858.56K | BUY | 88.82% | 556.47K | Dec 02 | View |
Dec 06, 2022 | Nicholas J. Singer | — | 283.29K | $3.28 | $929.18K | BUY | ∞ | 266.21K | Dec 02 | View |
Dec 05, 2022 | JOHN HALPERN | 10% OWNER | 335.92K | $3.28 | $1.10M | BUY | 291.48% | 451.17K | Dec 02 | View |
Browse insider trades on all stocks.